United States Point-of-Care Diagnostics Market to hit $106.35 billion by 2033 - Exclusive Report by DatamIntelligence

"Point of Care Diagnostics Market reached US$ 44.72 Billion in 2024 and is expected to reach US$ 106.35 Billion by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/point-of-care-diagnostics-market?sp

United States: Recent Industry Developments

✅ In October 2025, Abbott Laboratories USA launched its latest i-STAT handheld analyzer capable of multi-analyte testing within minutes, enhancing rapid diagnostics for emergency and primary care settings.

✅ In September 2025, BD (Becton, Dickinson and Company) USA received FDA approval for its rapid molecular test for respiratory pathogens, enabling faster detection and better infection control in clinical settings.

✅ In August 2025, QuidelOrtho USA completed the acquisition of a U.S.-based diagnostics startup specializing in AI-driven point-of-care testing platforms, strengthening its decentralized testing portfolio.

✅ In July 2025, Thermo Fisher Scientific USA invested in R&D to expand its range of point-of-care diagnostics for cardiac and metabolic biomarkers, supporting real-time decision-making in patient care.

Japan: Recent Industry Developments

✅ In October 2025, Sysmex Corporation Japan launched a portable point-of-care hematology analyzer offering rapid results with high precision, improving patient management in outpatient and rural clinics.

✅ In September 2025, Fujifilm Healthcare Japan received regulatory approvals for a compact point-of-care diagnostic device designed for infectious disease detection, ensuring accuracy and compliance.

✅ In August 2025, HORIBA Medical Japan entered a partnership with a domestic biotech company to co-develop advanced POC systems for chronic disease monitoring, expanding its diagnostic portfolio.

✅ In July 2025, Canon Medical Systems Japan invested in R&D for AI-enabled point-of-care devices integrating imaging and biomarker analysis, supporting faster diagnostics and clinical efficiency.

Point-of-care diagnostics Market: Drivers

The point-of-care diagnostics market is witnessing robust growth as healthcare systems increasingly shift toward decentralized testing for faster disease detection and improved patient outcomes. Point-of-care (POC) diagnostics enable rapid medical testing near the site of patient care-such as clinics, hospitals, or even homes-providing immediate results that support timely clinical decisions. Rising demand for early diagnosis, increasing prevalence of infectious and chronic diseases, and growing adoption of home healthcare solutions are driving market expansion. Technological advancements in biosensors, microfluidics, and molecular diagnostics are enhancing test accuracy, sensitivity, and ease of use. Additionally, the COVID-19 pandemic accelerated the adoption of POC testing, establishing it as a critical component of modern diagnostic workflows.

Integration of POC devices with digital health platforms, smartphone connectivity, and cloud-based data management is improving patient monitoring, disease tracking, and telemedicine applications. Companies are investing in R&D to develop portable, cost-effective, and multiplexed diagnostic systems capable of detecting multiple biomarkers simultaneously. The growing focus on personalized medicine, preventive healthcare, and rapid testing in emergency settings is creating new growth opportunities. Supportive regulatory approvals, government initiatives for accessible healthcare, and rising consumer awareness are further propelling adoption. With continuous technological innovation and increasing demand for real-time, decentralized testing, the point-of-care diagnostics market is poised for strong and sustained growth in the coming years.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/point-of-care-diagnostics-market?sp

Point-of-care diagnostics Market: Major Players

BD, QuidelOrtho Corporation, QIAGEN, Trinity Biotech plc, BioMérieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott Laboratories, Danaher Corporation, and SEKISUI MEDICAL CO., LTD., among others.

Segment Covered in the Point-of-care diagnostics Market:

By Product
Key product segments include Infectious Disease Testing Products, Blood Glucose Products, Blood Gas & Electrolyte Products, Hematology Testing Products, Urinalysis Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Profiling Products, Drug-of-Abuse Products, and Others. Infectious disease and glucose testing products dominate due to their broad diagnostic use and high patient demand.

By Technology
The market is segmented into Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Microfluidics, and Others. Molecular diagnostics and immunoassays lead the space for their accuracy and rapid detection capabilities across multiple disease categories.

By Application
Applications span Infectious Diseases, Hematology, Cardiology, Endocrinology, Oncology, Drug Testing, Neurology, and Others. Infectious diseases and oncology remain the primary focus areas, driven by rising prevalence and the need for early diagnosis.

By End User
End users include Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgery Centers (ASCs), and Home Care Settings. Hospitals and diagnostic labs account for the largest market share, while home care testing is rapidly expanding due to increasing patient convenience and point-of-care adoption.

Research Process:

Both primary and secondary data sources have been used in the Point-of-care diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Point-of-care diagnostics Market Research Industry:

➠ Who leads the Point-of-care diagnostics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Point-of-care diagnostics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Point-of-care diagnostics market growth?
➠ What are the dominant sales and distribution strategies in the Point-of-care diagnostics industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=point-of-care-diagnostics-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.